Evidence of managements failure:
Well that was before the Galaxy results got released. It's now quite clear why they've failed to secure a partner, no Pharma company wants to partner with Ganetespib once they take a look at the interim data. That was the missing piece investors didn't have until last week. Now the 1.5 year delay in securing a partner make sense. There isn't a blockbuster drug here, not even close.